110 Poster - Do patients with breast cancer receive the optimal personalized follow up?

J. van Middelkoop-van Hoeve, J. Ankersmid, L. Strobbe, M. Velting, D. Sprengers, Janneke Verloop, R. Schrijer, B. Kistemaker, S. Siesling

Research output: Contribution to journalMeeting AbstractAcademic

4 Downloads (Pure)

Abstract

Background: The incidence of breast cancer has increased in the last 15 years. Due to improved survival, the 10-year prevalence has increased even more, resulting in more focus on the late effects of cancer treatment and survivorship. Good quality of follow up and aftercare means that late effects of treatment and disease can be prevented or signaled at an early stage and that patients receive tailored care. However, it is unclear how optimal and efficient follow up and aftercare should look like, from the patients perspective as well as the perspective of health care organizations.
Original languageEnglish
Pages (from-to)S21-S22
JournalEuropean journal of cancer
Volume138
Issue numberSupplement 1
Early online date5 Oct 2020
DOIs
Publication statusPublished - Oct 2020
Event12th European Breast Cancer Conference, EBCC 2020 - Virtual Conference
Duration: 2 Oct 20203 Oct 2020
Conference number: 12
https://conferences.eortc.org/ebcc12/

Fingerprint

Dive into the research topics of '110 Poster - Do patients with breast cancer receive the optimal personalized follow up?'. Together they form a unique fingerprint.

Cite this